A new trademark application for COVID-KUSH was filed with the U.S. Patent and Trademark Office (USPTO), on July 30, 2020. The applicant is Anthony Ariza dba Covid-Kush of Santa Clara, California....
Given the current coronavirus pandemic, much has been discussed about possible vaccine trials and antiviral treatments to coronavirus. One patent directed to therapeutic use is U.S. Patent No....
On August 3, 2020, the Court of Appeals for the Federal Circuit issued a modified opinion in Illumina, Inc. v. Ariosa Diagnostics, Inc., reiterating its earlier opinion finding claims directed to...
On July 31, 2020, the Court of Appeals for the Federal Circuit denied American Axle’s petition for en banc review, in American Axle & Manuf., Inc. v. Neapco Holdings LLC, with those judges seeking...
U.S. Patent No. 10,512,629 B1 (‘629) issued on December 24, 2019, entitled ”Compositions Comprising a Cannabinoid and Spilanthol.” It was issued to inventor Zohar Koren of Gan Ner, Israel. The...
In a major ruling, the U.S. Supreme Court held in U.S.P.T.O. v. Booking.com B.V., that an otherwise generic mark used in commerce conveys source-identifying characteristics when used with the “.com”...
U.S. Patent No. 10,485,373 B1 (‘373) issued on November 26, 2019, entitled ”Method for Cannabinoid Delivery Into Beverages.” It was issued to inventors Rory Chesley Patrick Millikin of Kelowna,...
U.S. Patent No. 10,485,771 B2 (‘771) issued on November 26, 2019, entitled ”Methods of Regulating Cannabinoid Receptor Activity-Related Disorders and Diseases.” It was issued to inventors Irving W....
U.S. Patent No. 10,477,791 B2 (‘791) issued on November 19, 2019, entitled ”Method of Production of Phytocannabinoids for Use in Medical Treatments.” It was issued to inventor Peter Andrew Whitton...
U.S. Patent No. 10,456,435 B2 (‘435) issued on October 29, 2019, entitled ”Topical Antiviral Formulations and Methods of Using the Same.” It was issued to applicant/inventor Christopher A. McElvany...